New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
IO Biotech, Inc.
IOBT
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

71M

Biotechnology

Next Earning date - 11 Nov 2024

71M

Biotechnology

Next Earning date - 11 Nov 2024

1.08USD
Shape0.05 ( 4.85%)
favorite-chart

Relative Strenght

14
favorite-chart

Volume Buzz

-86%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

49%

Quote Panel

Shape
Updated October 12, 2024
1W 0.93 % 1M 43.81 % 3M -21.74 % 1Y -6.09 %

Key Metrics

Shape
  • Market Cap

    71.15M


  • Shares Outstanding

    65.88M


  • Share in Float

    44.87M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    1.08


  • Average Volume

    443890


  • Beta

    0.466


  • Range

    0.733-2.098


  • Industry

    Biotechnology


  • Website

    https://www.iobiotech.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

64.10x

P/S Ratio

0.74x

P/B Ratio

0.0

Debt/Equity

-7928.3%

Net Margin

$-1.3

EPS

How IOBT compares to sector?

P/E Ratio

Relative Strength

Shape

IOBT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1M

ShapeNaN%

2025-Revenue

$1.09

Shape-253%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Morgan Stanley

initialise

Previous: Not converted

2021-12-03

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.56
vs -36.88

Q4.22

arrow
arrow

N/A

-0.69
vs -0.83

Q1.23

arrow
arrow

N/A

-0.59
vs -0.60

Q2.23

arrow
arrow

N/A

-0.74
vs -0.64

Q3.23

arrow
arrow

N/A

-0.43
vs -0.56

Q4.23

arrow
arrow

N/A

-0.40
vs -0.69

Q1.24

arrow
arrow

N/A

-0.30
vs -0.59

Q2.24

arrow
arrow

N/A

-0.31
vs -0.74

Q3.24

arrow
arrow

N/A

-0.29
vs -0.43

Q4.24

arrow
arrow

N/A

-0.31
vs -0.40

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

1.1M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-10%

-0.10
vs -0.11

Q4.22

arrow
arrow

-14%

-0.14
vs -0.10

Q1.23

arrow
arrow

-14%

-0.14
vs -0.14

Q2.23

arrow
arrow

-20%

-0.20
vs -0.14

Q3.23

arrow
arrow

-14%

-0.14
vs -0.20

Q4.23

arrow
arrow

-20%

-0.20
vs -0.14

Q1.24

arrow
arrow

-17%

-0.17
vs -0.20

Q2.24

arrow
arrow

-21%

-0.21
vs -0.17

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

20

20
vs 18

11%

Q4.22

arrow
arrow

17

17
vs 20

-15%

Q1.23

arrow
arrow

17

17
vs 17

NA

Q2.23

arrow
arrow

15

15
vs 17

-12%

Q3.23

arrow
arrow

20

20
vs 15

33%

Q4.23

arrow
arrow

19

19
vs 20

-5%

Q1.24

arrow
arrow

18

18
vs 19

-5%

Q2.24

arrow
arrow

20

20
vs 18

11%

Earnings Growth

Latest News